Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET).
OBJECTIVE
To evaluate patients' self-reports of treatment efficacy with and without self-prompted memory aids regarding their clinical experiences obtained prior to treatment initiation.


METHODS
Double-blind, placebo-controlled trial with variable expected duration placebo lead-in and washout.


METHODS
Multisite (US) randomized clinical trial.


METHODS
Seventy-four patients with initial or recurrent DSM-IV diagnosis of major depression with symptoms of at least four weeks duration. A minimum Clinical Global Impression of Severity rating of Moderately Depressed and a clinician 17-item Hamilton Rating Scale for Depression score of 15 or greater, with the depressed mood item score of at least 2 were required for study entry.


METHODS
Patient global impression of improvement (PGI-I) ratings obtained using an interactive voice response (IVR) computer-automated telephone system prior to and following playback of impromptu patient recordings obtained prior to the start of treatment (MERET).


RESULTS
MERET PGI-I ratings differentiated the effects of drug treatment from placebo more effectively than did standard PGI-I ratings. The drug-placebo treatment effect size obtained using standard PGI-I ratings was 0.525, whereas the effect size with MERET PGI-I ratings was 0.612.


CONCLUSIONS
The enhanced drug-placebo separation appeared to be primarily due to increased patients' perceptions of drug treatment effectiveness. Patients perceiving the greatest degree of clinical improvement indicated more benefit from hearing the MERET recordings. MERET appears to be a viable method for enhancing patients' insights into the benefits of effective treatments by allowing them to use personal descriptions provided in their own words and voice.
Mundt
James C
JC
Healthcare Technology Systems, Inc., Madison, Wisconsin, USA. JMundt@healthtechsys.com
Debrota
David J
DJ
Greist
John H
JH
J Clin Psychopharmacol. 2001 Apr;21(2):251-2
11270933
Neuropsychopharmacology. 2005 Feb;30(2):405-16
15578008
J Clin Psychiatry. 2006 Jun;67(6):865-73
16848645
Psychol Med. 2004 Jan;34(1):73-82
14971628
J Psychiatr Res. 2002 Nov-Dec;36(6):383-90
12393307
J Clin Psychiatry. 2002;63 Suppl 2:8-13
15453008
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
14399272
J Clin Psychiatry. 2002 Apr;63(4):308-15
12000204
J Clin Psychopharmacol. 2002 Feb;22(1):40-5
11799341
JAMA. 1999 Sep 22-29;282(12):1157-62
10501119
Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70
15589385
J Psychiatr Res. 2000 Jan-Feb;34(1):3-10
10696827